Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001376474-25-000322
Filing Date
2025-04-11
Accepted
2025-04-10 19:47:38
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSTAX CORP - FORM 10-Q SEC FILING btax-20240930.htm   iXBRL 10-Q 609656
2 CERTIFICATION bstx_ex31z1.htm EX-31.1 9793
3 CERTIFICATION bstx_ex31z2.htm EX-31.2 9761
4 CERTIFICATION bstx_ex32z1.htm EX-32.1 3596
5 CERTIFICATION bstx_ex32z2.htm EX-32.2 3448
  Complete submission text file 0001376474-25-000322.txt   3032941

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT btax-20240930_cal.xml EX-101.CAL 22242
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT btax-20240930_def.xml EX-101.DEF 57820
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT btax-20240930_lab.xml EX-101.LAB 151205
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT btax-20240930_pre.xml EX-101.PRE 139002
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT btax-20240930.xsd EX-101.SCH 30921
67 EXTRACTED XBRL INSTANCE DOCUMENT btax-20240930_htm.xml XML 415212
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 25829561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)